Showing results (11-20 of 29) with videos related to
Sort By:
Pageof 3
Vascular|August 9, 2024
Contraindications to tissue plasminogen activator thrombolysis for acute lower extremity ischemiaNikita Singh, Tyler Santos, Ali Basil Ali, et al.JTO Clinical and Research Reports|November 8, 2021
Abemaciclib in Combination With Pembrolizumab for Stage IV KRAS-Mutant or Squamous NSCLC: A Phase 1b StudyJean-Louis Pujol, Johan Vansteenkiste, Luis Paz-Ares Rodríguez, et al.Journal for Immunotherapy of Cancer|August 6, 2020
Outcomes to first-line pembrolizumab in patients with PD-L1-high (≥50%) non-small cell lung cancer and a poor performance statusJoao V Alessi, Biagio Ricciuti, Elizabeth Jiménez-Aguilar, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 1, 2017
Radiation and PD-1 inhibition: Favorable outcomes after brain-directed radiationLuke R G Pike, Andrew Bang, Patrick Ott, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2019
Multicenter Phase I Study of Erdafitinib (JNJ-42756493), Oral Pan-Fibroblast Growth Factor Receptor Inhibitor, in Patients with Advanced or Refractory Solid TumorsRastislav Bahleda, Antoine Italiano, Cinta Hierro, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 30, 2023
Osimertinib and Selpercatinib Efficacy, Safety, and Resistance in a Multicenter, Prospectively Treated Cohort of EGFR-Mutant and RET Fusion-Positive Lung CancersJulia Rotow, Jyoti D Patel, Matthew P Hanley, et al.Archives of Pathology & Laboratory Medicine|April 16, 2024
Programmed Death Ligand-1 and Tumor Mutation Burden Testing of Patients With Lung Cancer for Selection of Immune Checkpoint Inhibitor Therapies: Guideline From the College of American Pathologists, Association for Molecular Pathology, International Association for the Study of Lung Cancer, Pulmonary Pathology Society, and LUNGevity FoundationLynette M Sholl, Mark Awad, Upal Basu Roy, et al.The Journal of Experimental Medicine|November 25, 2024
Hypoxia is linked to acquired resistance to immune checkpoint inhibitors in lung cancerCamila Robles-Oteíza, Katherine Hastings, Jungmin Choi, et al.Cancer Research|May 6, 2004
Three classes of genes mutated in colorectal cancers with chromosomal instabilityZhenghe Wang, Jordan M Cummins, Dong Shen, et al.Nature|March 19, 2026
Thymic health and immunotherapy outcomes in patients with cancerSimon Bernatz, Vasco Prudente, Suraj Pai, et al.Pageof 3